I had the pleasure of visiting Stockley Academy last week to give a talk as part of the Speakers for Schools scheme. Talking about Parkinson’s, I was very impressed by the students who asked some very insightful questions – hopefully they went away with a better idea as to what happens in the brain when people develop Parkinson’s.
A warm welcome to Dorien Roosen, who has started a PhD in the group. Her project is a collaboration between my lab here in Reading and Mark Cookson’s group at the National Institute on Aging in Bethesda, Maryland. Over the next three years Dorien is going to looking at some of the pathways linking LRRK2 to Parkinson’s disease.
I’ll let Dorien tell you a little bit more about herself:
“I graduated in bioscience engineering at the University of Leuven in June 2014. For my master thesis project, I worked for 9 months in the laboratory of Neurobiology and Gene Therapy of Prof. Veerle Baekelandt, doing research on a rat model for Parkinson’s disease. In September 2014, I joined the Laboratory of Neurogenetics at the National Institutes of Health for a one-year internship, studying the role of the Parkinson’s disease kinase LRRK2 in Dr Mark Cookson’s lab. My PhD project will be a collaboration between the lab of Dr Patrick Lewis at the University of Reading School of Pharmacy and the lab of Dr Mark Cookson at the NIH. During my PhD, starting October 2015, I will be investigating the role of LRRK2 and the regulation of macroautophagy.”